%0 Journal Article %T Development of Aseptic Renal Abscess in a Patient with Non-Small-Cell Lung Cancer with ALK Translocation during Crizotinib Treatment %A Luciana Franco do Prado de Carvalho %A Andrea Kazumi Shimada %A Manuel Santos da Cruz Neto %A Lucila Soares da Silva Rocha %A Publio Cesar Cavalcante Viana %A Esper George Kallas %A Artur Katz %J Advances in Lung Cancer %P 53-57 %@ 2169-2726 %D 2015 %I Scientific Research Publishing %R 10.4236/alc.2015.44007 %X Background: Crizotinib is a tyrosine kinase inhibitor of ALK, MET and ROS1. In a safety database trial, it was suggested an association of Crizotinib with the development of renal cyst in patients with non-small-cell lung cancer (NSCLC). Aim: To report an uncommon side effect of Crizotinib in a patient with NSLC. Case Presentation: We report the case of a 68-year-old woman with NSCLC who developed bilateral progressive aseptic renal abscesses during Crizotinib treatment. Conclusion: Further studies may be necessary to determinate the risk of renal cyst development and the management of these complications. %K Non-Small-Cell Lung Cancer %K Crizotinib %K Renal Abscesses %U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=63949